Esperion Therapeutics, Inc. is a public American pharmaceutical company focused on the development of bempedoic acid, an orally available small molecule designed to lower elevated levels of LDL-C. The company is headquartered in Ann Arbor, Michigan. The company's main products are NEXLIZET (bempedoic acid and ezetimibe) and NEXLETOL (bempedoic acid), the first approved oral, once-daily, non-statin LDL-Cholesterol (LDL-C) lowering combination medicine that is now available in U.S. pharmacies. Further products include NILEMDO (also a ATP Citrate Lyase inhibitor like NEXLETOL) and NUSTENDI (bempedoic acid and ezetimibe like NEXLIZET). More information...
According to PR-model, esperion.com is ranked 717,734th in multilingual Wikipedia, in particular this website is ranked 401,959th in English Wikipedia.
The website is placed before dimensionsmt.com and after codemystics.com in the BestRef global ranking of the most important sources of Wikipedia.
